News & Updates

Treatment with apremilast results in a significant reduction in genital psoriasis (G-PsO), as well as improvements in itch, pain, discomfort, redness, and quality of life (QoL), in patients with moderate-to-severe G-PsO who are intolerant to topical therapies, a study has shown.

In type 2 diabetes (T2D) patients with established heart failure (HF), use of alogliptin appears to contribute to an increased risk of HF exacerbation, reveals a study.

Remdesivir may cut the risk of symptoms and diagnoses associated with possible post-COVID conditions (PCC), otherwise known as long COVID.